JP6539290B2 - インスリン管理 - Google Patents

インスリン管理 Download PDF

Info

Publication number
JP6539290B2
JP6539290B2 JP2016567334A JP2016567334A JP6539290B2 JP 6539290 B2 JP6539290 B2 JP 6539290B2 JP 2016567334 A JP2016567334 A JP 2016567334A JP 2016567334 A JP2016567334 A JP 2016567334A JP 6539290 B2 JP6539290 B2 JP 6539290B2
Authority
JP
Japan
Prior art keywords
blood glucose
insulin
breakfast
meal
recommended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016567334A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017506757A (ja
JP2017506757A5 (cg-RX-API-DMAC7.html
Inventor
ロバート シー ブース
ロバート シー ブース
ハリー へブルホワイト
ハリー へブルホワイト
Original Assignee
アセコー インコーポレイテッド
アセコー インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アセコー インコーポレイテッド, アセコー インコーポレイテッド filed Critical アセコー インコーポレイテッド
Publication of JP2017506757A publication Critical patent/JP2017506757A/ja
Publication of JP2017506757A5 publication Critical patent/JP2017506757A5/ja
Application granted granted Critical
Publication of JP6539290B2 publication Critical patent/JP6539290B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H80/00—ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14288—Infusion or injection simulation
    • A61M2005/14296—Pharmacokinetic models
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A61M2005/1726—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure the body parameters being measured at, or proximate to, the infusion site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/18—General characteristics of the apparatus with alarm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3327—Measuring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A61M2205/507—Head Mounted Displays [HMD]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/581—Means for facilitating use, e.g. by people with impaired vision by audible feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • General Business, Economics & Management (AREA)
  • Business, Economics & Management (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2016567334A 2014-01-31 2015-01-15 インスリン管理 Active JP6539290B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201461934300P 2014-01-31 2014-01-31
US61/934,300 2014-01-31
US201462009575P 2014-06-09 2014-06-09
US62/009,575 2014-06-09
US14/524,918 US9233204B2 (en) 2014-01-31 2014-10-27 Insulin management
US14/524,918 2014-10-27
PCT/US2015/011574 WO2015116401A1 (en) 2014-01-31 2015-01-15 Insulin management

Publications (3)

Publication Number Publication Date
JP2017506757A JP2017506757A (ja) 2017-03-09
JP2017506757A5 JP2017506757A5 (cg-RX-API-DMAC7.html) 2017-12-07
JP6539290B2 true JP6539290B2 (ja) 2019-07-03

Family

ID=53753956

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016567334A Active JP6539290B2 (ja) 2014-01-31 2015-01-15 インスリン管理
JP2016567333A Active JP6511072B2 (ja) 2014-01-31 2015-01-15 インスリン管理

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016567333A Active JP6511072B2 (ja) 2014-01-31 2015-01-15 インスリン管理

Country Status (8)

Country Link
US (20) US9898585B2 (cg-RX-API-DMAC7.html)
EP (2) EP3046601B1 (cg-RX-API-DMAC7.html)
JP (2) JP6539290B2 (cg-RX-API-DMAC7.html)
AU (2) AU2015211382B2 (cg-RX-API-DMAC7.html)
CA (2) CA2928737C (cg-RX-API-DMAC7.html)
HK (1) HK1222349A1 (cg-RX-API-DMAC7.html)
IL (2) IL246937B (cg-RX-API-DMAC7.html)
WO (2) WO2015116397A1 (cg-RX-API-DMAC7.html)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
TW201333870A (zh) 2011-12-21 2013-08-16 艾登工具股份有限公司 決定病人胰島素療法的系統及方法
WO2014036177A1 (en) * 2012-08-30 2014-03-06 Abbott Diabetes Care Inc. Optimizing medication dosage based on analyte sensor data
US9561324B2 (en) 2013-07-19 2017-02-07 Bigfoot Biomedical, Inc. Infusion pump system and method
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
US9898585B2 (en) * 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
US11035818B2 (en) * 2014-08-15 2021-06-15 Roche Diabetes Care, Inc. Blood glucose meter with low cost user interface having programmed graphic indicators
WO2016102284A1 (en) * 2014-12-22 2016-06-30 Koninklijke Philips N.V. Wearable kit with smart patch
US10737024B2 (en) 2015-02-18 2020-08-11 Insulet Corporation Fluid delivery and infusion devices, and methods of use thereof
BG66892B1 (bg) * 2015-07-29 2019-05-31 „Смту“ Ад Адаптивна дозаторна система
WO2017031440A1 (en) * 2015-08-20 2017-02-23 Aseko, Inc. Diabetes management therapy advisor
US10275573B2 (en) 2016-01-13 2019-04-30 Bigfoot Biomedical, Inc. User interface for diabetes management system
US10780223B2 (en) 2016-01-14 2020-09-22 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
US10610643B2 (en) 2016-01-14 2020-04-07 Bigfoot Biomedical, Inc. Occlusion resolution in medication delivery devices, systems, and methods
US12383166B2 (en) 2016-05-23 2025-08-12 Insulet Corporation Insulin delivery system and methods with risk-based set points
WO2017213933A1 (en) * 2016-06-07 2017-12-14 Aseko, Inc. Managing insulin administration
US11462313B2 (en) * 2016-08-17 2022-10-04 Novo Nordisk A/S Systems and methods for adjusting a basal/bolus ratio in an insulin regimen
CN109863560B (zh) * 2016-08-25 2023-11-17 诺和诺德股份有限公司 基础胰岛素滴定的起始工具包
GB201614676D0 (en) * 2016-08-30 2016-10-12 Imp Innovations Automatic closed-loop glucose control with an adaptive meal bolus calculator
US11456073B2 (en) * 2016-09-09 2022-09-27 Dexcom, Inc. Systems and methods for CGM-based bolus calculator for display and for provision to medicament delivery devices
WO2018058041A1 (en) 2016-09-23 2018-03-29 Insulet Corporation Fluid delivery device with sensor
US11195607B2 (en) 2016-11-29 2021-12-07 Novo Nordisk A/S Starter kit for basal rate titration
EP3500161A4 (en) 2016-12-12 2020-01-08 Bigfoot Biomedical, Inc. ALARMS AND ALERTS FOR MEDICATION DELIVERY DEVICES AND RELATED SYSTEMS AND METHODS
WO2018132315A1 (en) * 2017-01-11 2018-07-19 Abbott Diabetes Care Inc. Systems, devices, and methods for experiential medication dosage calculations
US10758675B2 (en) 2017-01-13 2020-09-01 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
WO2018132754A1 (en) 2017-01-13 2018-07-19 Mazlish Bryan System and method for adjusting insulin delivery
EP3568859B1 (en) 2017-01-13 2025-12-10 Insulet Corporation Insulin delivery methods, systems and devices
US10500334B2 (en) 2017-01-13 2019-12-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10610644B2 (en) 2017-01-13 2020-04-07 Bigfoot Biomedical, Inc. Insulin delivery methods, systems and devices
US12249425B2 (en) 2017-06-15 2025-03-11 Novo Nordisk A/S Insulin titration algorithm based on patient profile
MA49422A (fr) * 2017-06-15 2020-04-22 Novo Nordisk As Titrage basal avec glycémie cible adaptative
WO2019010243A1 (en) * 2017-07-07 2019-01-10 Bayer Healthcare Llc APPARATUS, METHOD AND COMPUTER PROGRAM PRODUCT FOR EXCHANGING DATA EXCHANGE BETWEEN INJECTION SYSTEMS
CN107715230B (zh) * 2017-10-12 2019-10-01 微泰医疗器械(杭州)有限公司 基于云端大数据的胰岛素泵个体化配置优化系统
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
EP4492399A3 (en) 2018-05-04 2025-03-26 Insulet Corporation Safety constraints for a control algorithm-based drug delivery system
HUE053052T2 (hu) 2018-07-27 2021-06-28 Hoffmann La Roche Eljárás inzulinadagoló eszközzel beadandó bólus meghatározására, számítógépes programtermék és adatfeldolgozó eszköz
WO2020069406A1 (en) 2018-09-28 2020-04-02 Insulet Corporation Activity mode for artificial pancreas system
US11565039B2 (en) 2018-10-11 2023-01-31 Insulet Corporation Event detection for drug delivery system
USD920343S1 (en) 2019-01-09 2021-05-25 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
US12263327B2 (en) * 2019-11-14 2025-04-01 Medtronic Minimed, Inc. Synergistic features and functions related to operation of a medication delivery system and a meal transaction application
EP4354455B1 (en) 2019-12-06 2025-10-29 Insulet Corporation Techniques and devices providing adaptivity and personalization in diabetes treatment
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
US12036389B2 (en) 2020-01-06 2024-07-16 Insulet Corporation Prediction of meal and/or exercise events based on persistent residuals
US12458753B2 (en) * 2020-01-08 2025-11-04 Dexcom, Inc. Managing bolus doses
EP4100958A1 (en) 2020-02-03 2022-12-14 Insulet Corporation Use of fuzzy logic in predicting user behavior affecting blood glucose concentration
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11986630B2 (en) 2020-02-12 2024-05-21 Insulet Corporation Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
US12495994B2 (en) 2020-02-20 2025-12-16 Insulet Corporation Meal bolus subcategories in model based insulin therapy
CN115335918A (zh) * 2020-03-23 2022-11-11 豪夫迈·罗氏有限公司 临床分析仪上的临床决策支持
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
US20210393876A1 (en) * 2020-06-19 2021-12-23 Medtronic Minimed, Inc. Default carbohydrate consumption counts based on characteristics of persons
EP4185348A1 (en) 2020-07-22 2023-05-31 Insulet Corporation Open-loop insulin delivery basal parameters based on insulin delivery records
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
EP4221785B1 (en) 2020-09-30 2025-12-24 Insulet Corporation Drug delivery device with integrated optical-based glucose monitor
WO2022072618A1 (en) 2020-09-30 2022-04-07 Insulet Corporation Secure wireless communications between a glucose monitor and other devices
US11160925B1 (en) 2021-01-29 2021-11-02 Insulet Corporation Automatic drug delivery system for delivery of a GLP-1 therapeutic
US11941097B2 (en) 2021-03-01 2024-03-26 ID R&D Inc. Method and device for unlocking a user device by voice
EP4305636A1 (en) 2021-03-10 2024-01-17 Insulet Corporation A medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
WO2022235714A1 (en) * 2021-05-04 2022-11-10 Beta Bionics, Inc. Glucose level control systems and methods
US12496398B2 (en) 2021-05-28 2025-12-16 Insulet Corporation Threshold based automatic glucose control response
EP4101482A1 (en) 2021-06-07 2022-12-14 Insulet Corporation Exercise safety prediction based on physiological conditions
US11792714B2 (en) * 2021-06-16 2023-10-17 Medtronic Minimed, Inc. Medicine administration in dynamic networks
US20230060939A1 (en) * 2021-08-24 2023-03-02 Insulet Corporation Adjustment of insulin-to-carbohydrate ratio, correction factor, insulin dosage and timing of insulin delivery by a medicament delivery device
US11738144B2 (en) 2021-09-27 2023-08-29 Insulet Corporation Techniques enabling adaptation of parameters in aid systems by user input
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery
EP4646726A1 (en) 2023-01-06 2025-11-12 Insulet Corporation Automatically or manually initiated meal bolus delivery with subsequent automatic safety constraint relaxation
WO2025090855A1 (en) * 2023-10-26 2025-05-01 University Of Virginia Patent Foundation Targeted basal insulin titration using sparse and dense glucose measurements

Family Cites Families (378)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US561422A (en) 1896-06-02 Paul minnis
US4055175A (en) 1976-05-07 1977-10-25 Miles Laboratories, Inc. Blood glucose control apparatus
FR2387659A1 (fr) 1977-04-21 1978-11-17 Armines Dispositif de controle et regulation de la glycemie
US4151845A (en) 1977-11-25 1979-05-01 Miles Laboratories, Inc. Blood glucose control apparatus
US4403984A (en) 1979-12-28 1983-09-13 Biotek, Inc. System for demand-based adminstration of insulin
US4464170A (en) 1982-09-29 1984-08-07 Miles Laboratories, Inc. Blood glucose control apparatus and method
US4731726A (en) 1986-05-19 1988-03-15 Healthware Corporation Patient-operated glucose monitor and diabetes management system
US4981779A (en) 1986-06-26 1991-01-01 Becton, Dickinson And Company Apparatus for monitoring glucose
US5216597A (en) 1987-05-01 1993-06-01 Diva Medical Systems Bv Diabetes therapy management system, apparatus and method
US4850959A (en) 1988-08-02 1989-07-25 Bioresearch, Inc. Bioelectrochemical modulation of biological functions using resonant/non-resonant fields synergistically
US4947845A (en) 1989-01-13 1990-08-14 Pacesetter Infusion, Ltd. Method of maximizing catheter longevity in an implantable medication infusion system
US4911168A (en) 1989-01-13 1990-03-27 Pacesetter Infusion, Ltd. Method of screening and selecting intraperitoneal medication infusion pump candidates
US5101814A (en) 1989-08-11 1992-04-07 Palti Yoram Prof System for monitoring and controlling blood glucose
US5091190A (en) 1989-09-05 1992-02-25 Alza Corporation Delivery system for administration blood-glucose lowering drug
US5251126A (en) 1990-10-29 1993-10-05 Miles Inc. Diabetes data analysis and interpretation method
GB9024771D0 (en) 1990-11-14 1991-01-02 Axis Research Assay
GB9104037D0 (en) 1991-02-26 1991-04-10 Hospital For Sick The Children Process for the phosphorylation of insulin
SE9101381D0 (sv) 1991-05-07 1991-05-07 Tomas Moks Peptide hormone solution
US5956501A (en) 1997-01-10 1999-09-21 Health Hero Network, Inc. Disease simulation system and method
US6186145B1 (en) 1994-05-23 2001-02-13 Health Hero Network, Inc. Method for diagnosis and treatment of psychological and emotional conditions using a microprocessor-based virtual reality simulator
US7624028B1 (en) 1992-11-17 2009-11-24 Health Hero Network, Inc. Remote health monitoring and maintenance system
JPH08500123A (ja) 1993-01-25 1996-01-09 ザ ベス イスラエル ホスピタル アソシエイション Ｉｇｆ−ｉ感受性細胞のバリヤー特性の修飾方法，診断方法及びスクリーニング方法
US5917052A (en) 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
US5614224A (en) 1995-04-20 1997-03-25 Womack; Rick W. Nutritional supplement for diabetics
MY115050A (en) 1995-10-16 2003-03-31 Mead Johnson Nutrition Co Diabetic nutritional product having controlled absorption of carbohydrate
US5821217A (en) 1995-10-27 1998-10-13 Beth Israel Deaconess Medical Center, Inc. Enteral formulation: low in fat and containing protein hydrolysates
ATE278801T1 (de) 1995-11-22 2004-10-15 Medtronic Minimed Inc Detektion von biologischen molekülen unter verwendung von chemischer amplifikation und optischem sensor
WO1997026321A2 (en) 1996-01-19 1997-07-24 Board Of Regents, The University Of Texas System Recombinant expression of proteins from secretory cell lines
US8734339B2 (en) 1996-12-16 2014-05-27 Ip Holdings, Inc. Electronic skin patch for real time monitoring of cardiac activity and personal health management
NZ336865A (en) 1997-01-23 2001-01-26 Sumitomo Pharma Use of a therapeutic agent containing a neurotrophic factor for treatment of diabetes and hyperlipemia
US20010002269A1 (en) 1997-05-06 2001-05-31 Zhao Iris Ginron Multi-phase food & beverage
US6558351B1 (en) 1999-06-03 2003-05-06 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
US7267665B2 (en) 1999-06-03 2007-09-11 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
US5929055A (en) 1997-06-23 1999-07-27 The Research Foundation Of State University Of New York Therapeutic method for management of diabetes mellitus
WO1999017610A1 (en) 1997-10-02 1999-04-15 The Regents Of The University Of California Protein delivery by secretory gland expression
CO4970787A1 (es) 1997-12-23 2000-11-07 Lilly Co Eli Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
AU5916298A (en) 1998-01-09 1999-07-26 Amylin Pharmaceuticals, Inc. Amylin agonist pharmaceutical compositions containing insulin
AU2989699A (en) 1998-03-05 1999-09-20 Universal Health-Watch, Inc. Apparatus to non-invasively measure glucose or other constituents in aqueous humor using infra-red spectroscopy
US6024699A (en) 1998-03-13 2000-02-15 Healthware Corporation Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients
AU748432B2 (en) 1998-04-02 2002-06-06 Merck & Co., Inc. Antidiabetic agents
JP2002515417A (ja) 1998-05-19 2002-05-28 エスディジー、インコーポレイテッド 標的指向リポソーム薬剤送達システム
US6537806B1 (en) 1998-06-02 2003-03-25 University Of Washington Compositions and methods for treating diabetes
CN1324234A (zh) 1998-09-25 2001-11-28 格利科克斯有限公司 果糖胺氧化酶,拮抗剂和抑制剂
US6615081B1 (en) 1998-10-26 2003-09-02 Birinder R. Boveja Apparatus and method for adjunct (add-on) treatment of diabetes by neuromodulation with an external stimulator
US20070293742A1 (en) 1998-11-30 2007-12-20 Novo Nordisk A/S Medical System And A Method Of Controlling The System For Use By A Patient For Medical Self Treatment
EP1437674B2 (en) * 1998-11-30 2011-11-23 Novo Nordisk A/S A method for assisting a user in a medical self treatment
US6540672B1 (en) 1998-12-09 2003-04-01 Novo Nordisk A/S Medical system and a method of controlling the system for use by a patient for medical self treatment
US8700161B2 (en) 1999-03-05 2014-04-15 Metacure Limited Blood glucose level control
CA2370302A1 (en) 1999-04-27 2000-11-02 Benjamin Lee Hughes Insulin crystals for pulmonary administration
US6669663B1 (en) 1999-04-30 2003-12-30 Medtronic, Inc. Closed loop medicament pump
US6890568B2 (en) 1999-05-24 2005-05-10 Grant Pierce Method for management of blood glucose levels
US7806886B2 (en) 1999-06-03 2010-10-05 Medtronic Minimed, Inc. Apparatus and method for controlling insulin infusion with state variable feedback
AU5844300A (en) 1999-06-04 2000-12-28 Indian Council Of Medical Research Eugenia jambolina fruit extracts for treating diabetes
EP1196445A1 (en) 1999-06-29 2002-04-17 Eli Lilly And Company Insulin crystals for pulmonary administration
AU7582200A (en) 1999-09-15 2001-04-17 Midtronic Minimed, Inc. Glucose sensing molecules having selected fluorescent properties
DE19954233A1 (de) 1999-11-11 2001-05-31 Nutricia Nv Diabetikernahrung
US6572542B1 (en) 2000-03-03 2003-06-03 Medtronic, Inc. System and method for monitoring and controlling the glycemic state of a patient
AU5104601A (en) 2000-03-29 2001-10-08 Univ Virginia Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data
JP4580542B2 (ja) 2000-05-17 2010-11-17 株式會社バイオニア 肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物
JP2003533318A (ja) 2000-05-25 2003-11-11 ヘルセテック インコーポレイテッド 手首に取りつけられた装置を用いる生理的な監視
US6605039B2 (en) 2000-07-24 2003-08-12 Medtronic, Inc. Cell-based biosensors suitable for implantable medical device applications
WO2002009693A1 (en) 2000-08-02 2002-02-07 Pharmanutrients Method and compositions for prevention and/or treatment of diabetes and glucose modulation
US6365176B1 (en) 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
AU2001291189A1 (en) 2000-09-22 2002-04-02 Knobbe, Lim And Buckingham Method and apparatus for real-time estimation and control of pysiological parameters
AU2001212603A1 (en) 2000-11-01 2002-05-15 Biovan, Inc. Method for management of blood glucose levels
DE60133667T2 (de) 2000-11-30 2009-06-18 Arkray, Inc. Mit kommentareingabefunktion ausgestattete messvorrichtung
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
AU2002229926B2 (en) 2001-02-08 2005-12-01 Lifescan Scotland Limited A personal condition management system
US6927246B2 (en) 2001-02-15 2005-08-09 Medtronic Minimed, Inc. Polymers functionalized with fluorescent boronate motifs and methods for making them
DK1406641T3 (da) 2001-06-18 2009-05-04 Neptune Technologies & Bioress Krillekstrakter til forebyggelse og/eller behandling af cardiovaskulære sygdomme
US6544212B2 (en) 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
JP3775263B2 (ja) 2001-08-10 2006-05-17 ニプロ株式会社 記録媒体およびこの記録媒体を用いた血糖測定システム
EP1320322A1 (en) 2001-08-20 2003-06-25 Inverness Medical Limited Wireless diabetes management devices and methods for using the same
MY135783A (en) 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
US6740072B2 (en) 2001-09-07 2004-05-25 Medtronic Minimed, Inc. System and method for providing closed loop infusion formulation delivery
US6827702B2 (en) 2001-09-07 2004-12-07 Medtronic Minimed, Inc. Safety limits for closed-loop infusion pump control
KR20030025200A (ko) 2001-09-19 2003-03-28 (주)바이오니아 아밀라제의 활성을 억제할 수 있는 옥수수 추출물, 이를함유하는 비만증 또는 당뇨병 치료 또는 예방용 의약적조성물 및 식품 첨가물 그리고 그들의 제조방법
US7204823B2 (en) 2001-12-19 2007-04-17 Medtronic Minimed, Inc. Medication delivery system and monitor
AU2002346491A1 (en) 2001-12-19 2003-07-09 Eli Lilly And Company Crystalline compositions for controlling blood glucose
ES2284829T3 (es) 2002-01-25 2007-11-16 Laboratorios Silanes, S.A. De C.V. Composicion farmaceutica que se usa para controlar la glucosa en sangre en pacientes con diabetes de tipo 2.
US20030199445A1 (en) 2002-02-07 2003-10-23 Knudsen Lotte Bjerre Use of GLP-1 compound for treatment of critically ill patients
US7108680B2 (en) 2002-03-06 2006-09-19 Codman & Shurtleff, Inc. Closed-loop drug delivery system
TW200304372A (en) 2002-03-20 2003-10-01 Kanegafuchi Chemical Ind Compositions for diabetes
GB0206792D0 (en) 2002-03-22 2002-05-01 Leuven K U Res & Dev Normoglycemia
EP1498067A1 (en) 2002-04-25 2005-01-19 Matsushita Electric Industrial Co., Ltd. Dosage determination supporting device, injector, and health management supporting system
AU2003228777C1 (en) 2002-04-30 2009-08-13 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
US20060264886A9 (en) 2002-05-06 2006-11-23 Pettis Ronald J Method for altering insulin pharmacokinetics
JP2003319758A (ja) 2002-05-07 2003-11-11 Unitika Ltd Ｄ−グルコース吸収抑制方法及びｄ−グルコース吸収抑制剤
WO2003101177A2 (en) 2002-06-04 2003-12-11 Sequenom, Inc. Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions
WO2004002296A2 (en) 2002-06-27 2004-01-08 Sequenom, Inc. Therapeutic methods for reducing fat deposition and treating associated conditions
JPWO2004002473A1 (ja) 2002-06-28 2005-10-27 キッセイ薬品工業株式会社 血糖コントロール用医薬組成物
EP1382363A1 (en) 2002-07-15 2004-01-21 Novo Nordisk A/S Closed loop system for controlling blood glucose levels
FR2842735B1 (fr) 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
US8571801B2 (en) 2002-08-28 2013-10-29 Atkins Nutritionals, Inc. Methods and systems for determining and controlling glycemic responses
JP2004095048A (ja) 2002-08-30 2004-03-25 Toshiba Corp 不揮発性半導体メモリ
US7404796B2 (en) 2004-03-01 2008-07-29 Becton Dickinson And Company System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor
WO2004028469A2 (en) 2002-09-27 2004-04-08 Martek Biosciences Corporation Docohexaenoic acid for improved glycemic control
US7060059B2 (en) 2002-10-11 2006-06-13 Becton, Dickinson And Company System and method for initiating and maintaining continuous, long-term control of a concentration of a substance in a patient using a feedback or model-based controller coupled to a single-needle or multi-needle intradermal (ID) delivery device
US7137951B2 (en) 2002-10-23 2006-11-21 Joseph Pilarski Method of food and insulin dose management for a diabetic subject
KR20050086948A (ko) 2002-12-27 2005-08-30 디오벡스, 인코포레이티드 인슐린으로 인한 저혈당증을 예방하고 조절하기 위한조성물 및 방법
US9872890B2 (en) 2003-03-19 2018-01-23 Paul C. Davidson Determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients
CA2519249C (en) 2003-03-19 2012-11-27 Harry Hebblewhite Method and system for determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients
US7504118B2 (en) 2003-04-11 2009-03-17 Fhg Corporation Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport
JP2005029570A (ja) 2003-06-16 2005-02-03 Tokiwa Shokubutsu Kagaku Kenkyusho:Kk コロソリン酸の製造方法
US20050054818A1 (en) 2003-07-02 2005-03-10 Brader Mark Laurence Crystalline compositions for controlling blood glucose
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
WO2005041022A1 (en) 2003-10-24 2005-05-06 Judy Singley Method, system, and computer program for performing carbohydrate/insulin calculation based upon food weight
KR100567837B1 (ko) 2003-10-24 2006-04-05 케이제이헬스케어 주식회사 혈당측정이 가능한 이동통신단말기와 결합되는 인슐린펌프와, 인슐린 펌프의 제어정보 전송을 위한 네트워크시스템
US20080119421A1 (en) 2003-10-31 2008-05-22 Jack Tuszynski Process for treating a biological organism
US20050096637A1 (en) 2003-10-31 2005-05-05 Medtronic, Inc. Sensing food intake
CA2544425A1 (en) 2003-11-04 2005-05-12 Meiji Dairies Corporation Alpha-glucosidase activity inhibitor
CN101912641B (zh) 2003-11-06 2017-03-01 生命扫描有限公司 带有事件通知装置的药物配送笔
US8532730B2 (en) 2006-10-04 2013-09-10 Dexcom, Inc. Analyte sensor
EP1711101A1 (en) 2004-01-15 2006-10-18 Glucon Inc. Wearable glucometer
WO2005081173A1 (en) 2004-02-19 2005-09-01 Edward Henry Mathews Diabetes slide ruler for blood glucose control
WO2006004574A2 (en) 2004-02-19 2006-01-12 Abbott Laboratories Method for using gamma cyclodextrin to control blood glucose and insulin secretion
WO2005081119A2 (en) 2004-02-19 2005-09-01 Edward Henry Mathews Interactive diabetes education system
WO2005081171A2 (en) 2004-02-19 2005-09-01 Edward Henry Mathews Insulin bolus calculator for mobile communication device
WO2005081170A2 (en) 2004-02-19 2005-09-01 Edward Henry Mathews Diabetes management and patient database system via mobile communication device
US7651845B2 (en) 2004-05-13 2010-01-26 The Regents Of The University Of California Method and apparatus for glucose control and insulin dosing for diabetics
WO2005110222A1 (en) 2004-05-18 2005-11-24 Okto Medical Appliance Co., Ltd. Blood sugar control system and medical treatment method using the same
WO2006006286A1 (ja) 2004-07-09 2006-01-19 Meiji Dairies Corporation Pparおよび／またはppar関連因子産生増強組成物
WO2006022633A1 (en) 2004-07-22 2006-03-02 Sequenom, Inc. Methods for identifying a risk of type ii diabetes and treatments thereof
WO2006022636A1 (en) 2004-07-22 2006-03-02 Sequenom, Inc. Methods for identifying risk of type ii diabetes and treatments thereof
CA2574610A1 (en) 2004-07-22 2006-03-02 Sequenom, Inc. Methods for identifying risk of type ii diabetes and treatments thereof
WO2006022629A1 (en) 2004-07-22 2006-03-02 Sequenom, Inc. Methods of identifying risk of type ii diabetes and treatments thereof
WO2006022634A1 (en) 2004-07-22 2006-03-02 Sequenom, Inc. Methods for identifying risk of type ii diabetes and treatments thereof
WO2006022638A1 (en) 2004-07-22 2006-03-02 Sequenom, Inc. Methods for identifying risk of type ii diabetes and treatments thereof
WO2006022619A2 (en) 2004-07-22 2006-03-02 Sequenom, Inc. Methods for identifying risk of type ii diabetes and treatments thereof
US20060040003A1 (en) 2004-08-10 2006-02-23 Alvin Needleman Dietary supplement for supressing appetite, enhancing and extending satiety, improving glycemic control, and stimulant free
US20070060549A1 (en) 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
US20120213886A1 (en) 2004-08-25 2012-08-23 U.S. Dept. Of Veterans Affairs Compositions and Methods to Lower Glycohemoglobin Levels
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US7291107B2 (en) 2004-08-26 2007-11-06 Roche Diagnostics Operations, Inc. Insulin bolus recommendation system
EP1698898A3 (en) 2004-09-21 2006-10-11 Foundation of Biomedical Research of the Academy of Athens Prognostic, diagnostic and therapeutic significance in detecting and using TIN-antigen (Tubulo-Interstitial nephritis antigen) and its segments
US20060078593A1 (en) 2004-09-27 2006-04-13 Strozier Deborah C Nutritional compostions comprising a soluble viscous fiber in a solid crisp matrix
WO2006044556A2 (en) 2004-10-14 2006-04-27 Galileo Pharmaceuticals, Inc. Dual inhibitors of lipoxygenase for treating diabetes
US8117020B2 (en) 2004-12-03 2012-02-14 Roche Diagnostics Operations, Inc. Method to determine the degree and stability of blood glucose control in patients with diabetes mellitus via creation and continuous updating of new statistical indicators
ES1059144Y (es) 2004-12-17 2005-07-01 Marin Jose Fuentes Dispositivo limpiador
ITMI20050010A1 (it) 2005-01-05 2006-07-06 Aboca S P A Composizioni farmaceutiche nutraceutiche dietetiche nutrizionali a base di fibre vegetali
CA2491763A1 (en) 2005-01-06 2006-07-06 Tassos P. Anastassiades Blood glucose control with n-acylated glucosamines
WO2006079124A2 (en) 2005-01-24 2006-07-27 Edward Henry Mathews Apparatus and method for predicting the effect of ingested foodstuff or exercise on blood sugar level of patient and suggesting a corrective action
US20060173260A1 (en) 2005-01-31 2006-08-03 Gmms Ltd System, device and method for diabetes treatment and monitoring
US7390663B2 (en) 2005-02-23 2008-06-24 Streck, Inc. Process, composition and kit for providing a stable whole blood calibrator/control
US20060188995A1 (en) 2005-02-24 2006-08-24 Ryan Wayne L Process, composition and kit for providing a stable whole blood calibrator/control
KR100750988B1 (ko) 2005-03-18 2007-08-22 주식회사 유니젠 천연물유래 진세노사이드를 포함하는 당뇨 또는혈당조절이상의 예방 또는 치료용 약학 조성물
BRPI0500959A (pt) 2005-03-23 2006-11-21 Unicamp uso farmacológico de inibidor da expressão da proteìna coativador 1 alfa do receptor ativado por proliferador do peroxisoma (pgc-1(alfa)) para o tratamento de diabetes mellitus, resistência à insulina e sìndrome metabólica, seu composto e sua composição farmacêuticos
US20120065482A1 (en) 2005-04-08 2012-03-15 Mark Ries Robinson Determination of blood pump system performance and sample dilution using a property of fluid being transported
US20090054753A1 (en) 2007-08-21 2009-02-26 Mark Ries Robinson Variable Sampling Interval for Blood Analyte Determinations
JP2009506978A (ja) 2005-04-27 2009-02-19 メッサデク ジャアル インスリン類の併用
US20060263450A1 (en) 2005-05-17 2006-11-23 Julius Oben Method and composition for reducing body weight and improving control of body lipids
US7509156B2 (en) 2005-05-18 2009-03-24 Clarian Health Partners, Inc. System for managing glucose levels in patients with diabetes or hyperglycemia
WO2006130901A1 (en) 2005-06-07 2006-12-14 Bayer Healthcare Ag Control of metabolic abnormalities
US8251904B2 (en) 2005-06-09 2012-08-28 Roche Diagnostics Operations, Inc. Device and method for insulin dosing
WO2006136423A2 (en) 2005-06-24 2006-12-28 Dsm Ip Assets B.V. Medicament for the treatment of impaired glucose metabolism
US9204826B2 (en) 2005-07-29 2015-12-08 Universita Degli Studi Di Udine System and method for preventing hypoglycaemia in a human type 1 diabetic patient during physical activity
CN101232899A (zh) 2005-08-01 2008-07-30 曼金德公司 维持产胰岛素细胞功能的方法
US20070078314A1 (en) 2005-09-30 2007-04-05 Grounsell Richard L System and method for measuring and predicting insulin dosing rates
US7704226B2 (en) 2005-11-17 2010-04-27 Medtronic Minimed, Inc. External infusion device with programmable capabilities to time-shift basal insulin and method of using the same
US20070168224A1 (en) 2005-11-22 2007-07-19 Letzt Alan M Advanced diabetes management system (adms)
US8557274B2 (en) 2005-12-06 2013-10-15 Purdue Research Foundation Slowly digesting starch and fermentable fiber
US20070168136A1 (en) * 2006-01-19 2007-07-19 Booth Robert C System and method for assessing diabetic conditions
US8057840B2 (en) 2006-01-25 2011-11-15 Tate & Lyle Ingredients Americas Llc Food products comprising a slowly digestible or digestion resistant carbohydrate composition
US8346335B2 (en) 2008-03-28 2013-01-01 Abbott Diabetes Care Inc. Analyte sensor calibration management
US7824333B2 (en) 2006-03-31 2010-11-02 Lifescan, Inc. Diabetes management methods and systems
GB2436873A (en) 2006-04-07 2007-10-10 Univ Cambridge Tech Blood glucose monitoring systems
US20070282186A1 (en) 2006-05-02 2007-12-06 Adrian Gilmore Blood glucose monitor with an integrated data management system
US8548544B2 (en) 2006-06-19 2013-10-01 Dose Safety System, method and article for controlling the dispensing of insulin
CA2655566A1 (en) 2006-06-30 2008-01-10 Healthy Interactions, Inc. System, method, and device for providing health information
CN101489578A (zh) 2006-07-14 2009-07-22 浦项工科大学校产学协力团 表皮生长因子增加胰岛素分泌并降低血糖
WO2008013324A1 (en) 2006-07-28 2008-01-31 National University Corporation Kanazawa University Use of diabetes-related, liver-derived secreted protein in diagnosis or treatment of type-2 diabetes or vascular disorder
US9056165B2 (en) 2006-09-06 2015-06-16 Medtronic Minimed, Inc. Intelligent therapy recommendation algorithm and method of using the same
US20080172030A1 (en) 2006-10-17 2008-07-17 Blomquist Michael L Insulin pump having aweekly schedule
WO2008073609A2 (en) 2006-11-01 2008-06-19 Philip Michael Sher Device for predicting and managing blood glucose concentration by analyzing the effect of, and controlling, pharmacodynamic insulin unit equivalents
WO2008057384A2 (en) 2006-11-02 2008-05-15 The University Of North Carolina At Chapel Hill Methods and systems for determining an intravenous insulin infusion rate
US20080306353A1 (en) 2006-11-03 2008-12-11 Douglas Joel S Calculation device for metabolic control of critically ill and/or diabetic patients
US20080119705A1 (en) 2006-11-17 2008-05-22 Medtronic Minimed, Inc. Systems and Methods for Diabetes Management Using Consumer Electronic Devices
WO2008067245A2 (en) 2006-11-29 2008-06-05 University Of Maryland, Baltimore Determining insulin pump rate for tight glycemic control
US20080139910A1 (en) 2006-12-06 2008-06-12 Metronic Minimed, Inc. Analyte sensor and method of using the same
US20080214919A1 (en) 2006-12-26 2008-09-04 Lifescan, Inc. System and method for implementation of glycemic control protocols
US7946985B2 (en) 2006-12-29 2011-05-24 Medtronic Minimed, Inc. Method and system for providing sensor redundancy
US7734323B2 (en) 2007-01-24 2010-06-08 Smiths Medical Asd, Inc. Correction factor testing using frequent blood glucose input
US20080228056A1 (en) 2007-03-13 2008-09-18 Michael Blomquist Basal rate testing using frequent blood glucose input
US20080234943A1 (en) 2007-03-20 2008-09-25 Pinaki Ray Computer program for diabetes management
US20080249386A1 (en) 2007-04-04 2008-10-09 Pronia Medical Systems, Llc Systems, Methods, and Computer Program Product for Improved Management of Medical Procedures for Patients on Medical Protocols
US20080255707A1 (en) 2007-04-10 2008-10-16 Hebblewhite Harry R Method and system for categorizing blood glucose tests at test time in a portable device or later in a downloading program and then analyzing the categories separately
JP2010524554A (ja) 2007-04-19 2010-07-22 シー・ジー・エム・３・リミテツド 血液アナライトレベルを監視および制御するための装置システムおよび方法
ES2693432T3 (es) 2007-06-21 2018-12-11 F. Hoffmann-La Roche Ag Método y dispositivo para prevenir la hipoglucemia
WO2009005957A1 (en) 2007-06-29 2009-01-08 Roche Diagnostics Gmbh Apparatus and method for remotely controlling an ambulatory medical device
US20090036753A1 (en) 2007-07-31 2009-02-05 King Allen B Continuous glucose monitoring-directed adjustments in basal insulin rate and insulin bolus dosing formulas
EP2178546A1 (en) 2007-08-21 2010-04-28 ATP Marketing & Promotion AG Herbal formulations for controlling blood glucose levels in patients with diabetes
US7943163B2 (en) 2007-08-22 2011-05-17 Response Scientific, Inc. Medical food or nutritional supplement, method of manufacturing same, and method of managing diabetes
US7998069B2 (en) 2007-09-11 2011-08-16 Roche Diagnostics Operations, Inc. Mask algorithms for health management systems
DE102007047351A1 (de) * 2007-10-02 2009-04-09 B. Braun Melsungen Ag System und Verfahren zur Überwachung und Regelung von Blutglukosewerten
TWI348910B (en) 2007-10-29 2011-09-21 Univ Taipei Medical Composition for controlling blood glucose and method thereof
WO2009075925A1 (en) 2007-12-13 2009-06-18 Shaya Steven A Method and apparatus to calculate diabetic sensitivity factors affecting blood glucose
WO2009081403A2 (en) 2007-12-26 2009-07-02 Medingo Ltd. Maintaining glycemic control during exercise
US20090177147A1 (en) 2008-01-07 2009-07-09 Michael Blomquist Insulin pump with insulin therapy coaching
US20090238879A1 (en) 2008-01-24 2009-09-24 Northwestern University Delivery scaffolds and related methods of use
US20090214511A1 (en) 2008-02-21 2009-08-27 Trung Hong Tran Digestible compositions of inulin for managing blood glucose levels
US8317699B2 (en) 2008-02-29 2012-11-27 Roche Diagnostics Operations, Inc. Device and method for assessing blood glucose control
US7957059B2 (en) 2008-03-11 2011-06-07 Bausch & Lomb Incorporated Device and method for demonstrating optical effects
US20090240127A1 (en) 2008-03-20 2009-09-24 Lifescan, Inc. Methods of determining pre or post meal time slots or intervals in diabetes management
US8396528B2 (en) 2008-03-25 2013-03-12 Dexcom, Inc. Analyte sensor
US20090242399A1 (en) 2008-03-25 2009-10-01 Dexcom, Inc. Analyte sensor
US20090247982A1 (en) 2008-03-27 2009-10-01 Lifescan Inc. Medical Device Mechanical Pump
US8185412B1 (en) 2008-03-28 2012-05-22 Mahesh Harpale Method and apparatus for chronic care treatment control with custom named-type factors and user estimation error correction
WO2009124111A2 (en) 2008-04-01 2009-10-08 Trustees Of Boston University Glucose sensor employing semiconductor nanoelectronic device
US9220456B2 (en) 2008-04-04 2015-12-29 Hygieia, Inc. Systems, methods and devices for achieving glycemic balance
WO2009146121A2 (en) 2008-04-04 2009-12-03 Hygieia, Inc. Apparatus for optimizing a patient's insulin dosage regimen
TWI394580B (zh) 2008-04-28 2013-05-01 Halozyme Inc 超快起作用胰島素組成物
US20100256047A1 (en) 2009-04-03 2010-10-07 Lifescan, Inc. Analyte Measurement and Management Device and Associated Methods
US20090281519A1 (en) 2008-05-12 2009-11-12 Rao R Harsha Automated system and method for diabetes control
US8924159B2 (en) 2008-05-30 2014-12-30 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
JP5551691B2 (ja) 2008-06-26 2014-07-16 ラボラトリオス シラネス、エセ．ア．デ セ．べ． 血糖制御のための新規グリシン酸メトホルミン塩
IT1396465B1 (it) 2008-07-10 2012-12-14 B G Informatica S R L Metodo per la definizione e la gestione interattiva di un trattamento per il controllo del tasso glicemico nel paziente diabetico e dispositivo integrato che attua tale metodo
CA2731031A1 (en) 2008-07-18 2010-01-21 Lifescan, Inc. Analyte measurement and management device and associated methods
KR100918776B1 (ko) 2009-04-20 2009-09-24 계명대학교 산학협력단 폴리에틸렌 글리콜과 갈레이트 카테킨을 이용한 혈당상승 억제 조성물
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
WO2010021761A1 (en) 2008-08-20 2010-02-25 Bayer Healthcare Llc Health management supply organizing system and methods
EP2355669A2 (en) 2008-09-23 2011-08-17 Rubicon Research Private Limited Dietary fiber compositions
EP2179661A1 (en) 2008-10-23 2010-04-28 Generale Biscuit Biscuit comprising guar gum in a rod-like form
US8992464B2 (en) 2008-11-11 2015-03-31 Hygieia, Inc. Apparatus and system for diabetes management
US8527208B2 (en) 2008-11-17 2013-09-03 Roche Diagnostics International Ag Prandial blood glucose excursion optimization method via computation of time-varying optimal insulin profiles and system thereof
US20120011125A1 (en) 2008-12-23 2012-01-12 Roche Diagnostics Operations, Inc. Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
US20100160740A1 (en) 2008-12-24 2010-06-24 Gary Cohen Use of Patterns in a Therapy Management System
US20100174553A1 (en) 2008-12-24 2010-07-08 Medtronic Minimed, Inc. Diabetes Therapy Management System
US9330237B2 (en) 2008-12-24 2016-05-03 Medtronic Minimed, Inc. Pattern recognition and filtering in a therapy management system
US20100161346A1 (en) 2008-12-24 2010-06-24 Kristen Getschmann Systems and Methods for Providing Bolus Dosage Recommendations
US8198320B2 (en) 2008-12-31 2012-06-12 Taipei Medical University Hypoglycemic activity of osthole
JP5721637B2 (ja) 2009-01-07 2015-05-20 海▲東▼ 黄 ヒトグルコキナーゼ変異体コード遺伝子、そのコードされた酵素、組換えベクターおよび宿主、その医薬組成物、使用および疾病の予防と治療の方法
WO2010083570A1 (en) 2009-01-23 2010-07-29 The University Of Sydney Novel metabolic disease therapy
US20140363794A1 (en) 2009-01-26 2014-12-11 EosHealth, Inc. Diabetic Patients Compliance and Outcomes by Publicizing that Increased Compliance Improves Blood Glucose Control and Outcomes
BRPI1008849B8 (pt) 2009-02-04 2021-06-22 Sanofi Aventis Deutschland dispositivo médico e método para controle glicêmico
CA2750052C (en) 2009-02-04 2017-08-22 Sanofi-Aventis Deutschland Gmbh Medical system and method for providing glycemic control based on glycemic response information
US20120053843A1 (en) 2009-02-04 2012-03-01 Sanofi-Aventis Deutschland Gmbh Medical device and method for providing information for glycemic control
EP2393415B1 (en) 2009-02-04 2015-11-25 Sanofi-Aventis Deutschland GmbH Medical system and method for providing information for glycemic control
CN102308278A (zh) 2009-02-04 2012-01-04 雅培糖尿病护理公司 多功能分析物测试装置及其方法
US20100213060A1 (en) 2009-02-23 2010-08-26 Bio-Rad Laboratories, Inc. Aqueous transfer buffer
KR20120047841A (ko) 2009-02-26 2012-05-14 몰 리서치 어플리케이션스 엘티디 당뇨병 관련 치료의 자동 감시를 위한 방법 및 시스템
WO2010111660A1 (en) 2009-03-27 2010-09-30 Dexcom, Inc. Methods and systems for promoting glucose management
BRPI1011465A2 (pt) 2009-04-14 2015-08-25 Abbott Lab Emulsões de altas fibras nutricionais para controle da glicose do sangue
US8467972B2 (en) 2009-04-28 2013-06-18 Abbott Diabetes Care Inc. Closed loop blood glucose control algorithm analysis
WO2010135646A1 (en) 2009-05-22 2010-11-25 Abbott Diabetes Care Inc. Usability features for integrated insulin delivery system
US8398616B2 (en) 2009-05-22 2013-03-19 Abbott Diabetes Care Inc. Safety layer for integrated insulin delivery system
EP2433235A2 (en) 2009-05-22 2012-03-28 Abbott Diabetes Care, Inc. Safety features for integrated insulin delivery system
GB2471066A (en) 2009-06-10 2010-12-22 Dna Electronics Ltd A glucagon pump controller
US9687194B2 (en) 2009-06-17 2017-06-27 Medtronic Minimed, Inc. Closed-loop glucose and/or insulin control system
US9218453B2 (en) 2009-06-29 2015-12-22 Roche Diabetes Care, Inc. Blood glucose management and interface systems and methods
US20100331652A1 (en) 2009-06-29 2010-12-30 Roche Diagnostics Operations, Inc. Modular diabetes management systems
BRPI1015133A2 (pt) 2009-06-30 2016-04-19 Lifescan Scotland Ltd sistemas para o gerenciamento de diabetes e métodos
CN102481101A (zh) 2009-06-30 2012-05-30 生命扫描有限公司 用于计算基础胰岛素治疗的被分析物测试方法和设备
CN102018766B (zh) 2009-09-16 2013-03-06 博仲盛景医药技术（北京）有限公司 一种植物提取物、其提取方法和用途及含有这种提取物的组合物
US20110071464A1 (en) 2009-09-23 2011-03-24 Medtronic Minimed, Inc. Semi-closed loop insulin delivery
KR101632308B1 (ko) 2009-09-23 2016-06-21 삼성전자주식회사 혈당 관리 정보를 제공하는 방법 및 장치
CA3077994C (en) * 2009-09-29 2022-06-21 Lifescan Scotland Limited Analyte testing method and device for diabetes management
US8345399B2 (en) * 2009-10-01 2013-01-01 The Trustees For The Time Being Of The Philip Edward Lawrence Risi Trust Electrical protection assembly and system
JP2011083052A (ja) 2009-10-02 2011-04-21 Panasonic Electric Works Co Ltd 負荷制御システム
CN102574984B (zh) 2009-10-09 2014-09-17 汉高股份有限及两合公司 潜在性固化剂及包含其的环氧树脂组合物
WO2011050337A1 (en) 2009-10-22 2011-04-28 Abbott Diabetes Care Inc. Methods for modeling insulin therapy requirements
US20110115894A1 (en) 2009-11-19 2011-05-19 Daniel Rogers Burnett Device and method for diagnosis and monitoring of neural, opthalmologic and retinal disorders
US8771251B2 (en) 2009-12-17 2014-07-08 Hospira, Inc. Systems and methods for managing and delivering patient therapy through electronic drug delivery systems
RU2012130439A (ru) 2009-12-18 2014-01-27 Др Редди'З Лабораториз, Лимитед Композиция балаглитазона и способы ее применения
US8759284B2 (en) 2009-12-24 2014-06-24 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
WO2011089600A1 (en) 2010-01-20 2011-07-28 Medingo Ltd. A method and device for improving glycemic control
WO2011094352A1 (en) 2010-01-27 2011-08-04 Baylor Research Institute In-vivo non-viral gene delivery of human vascular endothelial growth factor following islet transplantation
US8579879B2 (en) 2010-02-19 2013-11-12 Medtronic Minimed, Inc. Closed-loop glucose control startup
US20110213332A1 (en) 2010-03-01 2011-09-01 Koorosh Mozayeny Medication delivery system
US9089292B2 (en) 2010-03-26 2015-07-28 Medtronic Minimed, Inc. Calibration of glucose monitoring sensor and/or insulin delivery system
WO2012161670A2 (en) 2010-04-07 2012-11-29 Incube Labs, Llc Method for treating diabetes and other glucose regulation disorders using stem cells
US20120197358A1 (en) 2010-04-09 2012-08-02 Prescott Marvin A Light Therapy for Treating or Managing Diabetes and Metabolic Syndrome
JP2011237408A (ja) 2010-04-14 2011-11-24 Arkray Inc 生体情報測定装置、生体情報測定装置における照明方法、および生体情報測定方法
US9387279B2 (en) 2010-05-05 2016-07-12 The Governing Council Of The University Of Toronto Implantable-glucose responsive insulin delivery device
US8532933B2 (en) 2010-06-18 2013-09-10 Roche Diagnostics Operations, Inc. Insulin optimization systems and testing methods with adjusted exit criterion accounting for system noise associated with biomarkers
US10561785B2 (en) 2010-06-22 2020-02-18 Medtronic Minimed, Inc. Method and/or system for closed-loop control of glucose to a treatment range
US8543354B2 (en) 2010-06-23 2013-09-24 Medtronic Minimed, Inc. Glucose sensor signal stability analysis
US20120003339A1 (en) 2010-07-02 2012-01-05 Minacapelli Pompeo Compositions and methods for controlling blood glucose levels
US20120006100A1 (en) 2010-07-06 2012-01-12 Medtronic Minimed, Inc. Method and/or system for determining blood glucose reference sample times
US8828390B2 (en) 2010-07-09 2014-09-09 Universitat Zurich Uses of NOGO-A inhibitors and related methods
US8870807B2 (en) 2010-07-19 2014-10-28 Surag Mantri Gastro-intestinal compression device
JP5905004B2 (ja) 2010-07-23 2016-04-20 アヴァセン， インコーポレイテッド 熱エネルギーの治療的適用のための方法およびシステム
WO2012010298A1 (en) 2010-07-23 2012-01-26 Roche Diagnostics Gmbh System and method considering the effect of physical activity on the glucoregulatory system
EP2603133A1 (en) 2010-08-10 2013-06-19 Roche Diagnostics GmbH Method and system for improving glycemic control
WO2012024270A1 (en) 2010-08-17 2012-02-23 Abbott Laboratories Nutritional composition comprising cereal beta-glucan and salacia extract
US8206340B2 (en) 2010-08-18 2012-06-26 Thuban, Inc. Integrated glucose monitor and insulin injection pen with automatic emergency notification
US20120058942A1 (en) 2010-09-03 2012-03-08 John Dupre Methods for controlling blood-glucose levels in insulin-requiring subjects
WO2012047800A1 (en) 2010-10-06 2012-04-12 Abbott Laboratories Methods for increasing muscle glucose uptake and decreasing muscle recovery time using amino acid blend
US8588687B2 (en) 2010-10-15 2013-11-19 Roche Diagnostics Operations, Inc. Coexistence of multiple radios in a medical device
WO2012097428A1 (en) 2010-10-27 2012-07-26 Prometic Biosciences Inc. Compounds and pharmaceutical compositions for uses in diabetes
US8919180B2 (en) 2010-10-28 2014-12-30 Medtronic Minimed, Inc. Determination and application of glucose sensor reliability indicator and/or metric
US8657746B2 (en) 2010-10-28 2014-02-25 Medtronic Minimed, Inc. Glucose sensor signal purity analysis
EP2633456B1 (en) 2010-10-31 2019-09-04 Trustees of Boston University Blood glucose control system
US8349612B2 (en) 2010-11-15 2013-01-08 Roche Diagnostics Operations, Inc. Guided structured testing kit
CA2846227A1 (en) 2010-11-16 2012-05-24 University Of Medicine And Dentistry Of New Jersey Treatment of type ii diabetes and diabetes-associated diseases with safe chemical mitochondrial uncouplers
US20120295985A1 (en) 2010-11-19 2012-11-22 Miller Guy M Methods for improving blood glucose control
CN102462736B (zh) 2010-11-19 2015-07-15 北京唐安营养保健品有限公司 肉桂水提取物的制备方法
US8329232B2 (en) 2010-11-23 2012-12-11 Beijing Tang-An Nutrition & Healthcare Products Co. Ltd. Process for preparing water extract of cinnamon
ES2396844B1 (es) 2010-12-01 2014-01-27 Universitat Politècnica De Catalunya Sistema y método para la estimación simultánea y no invasiva de la glucosa en la sangre, nivel de glucocorticoides y presión arterial
EP2647703A4 (en) 2010-12-01 2014-05-14 Kikkoman Corp E. COLI TRANSFORMANT, PROCESS FOR PRODUCTION OF FLAVIN-RELATED GLUCOSE DEHYDROGENASE USING THE SAME, AND FLAVIN-RELATED MUTANT GLYCOSIDE DEHYDROGENASE
JP5969392B2 (ja) 2010-12-02 2016-08-17 キッコーマン株式会社 フラビン結合型グルコースデヒドロゲナーゼ、フラビン結合型グルコースデヒドロゲナーゼの製造方法およびそれに用いる酵母形質転換体
MX2013007189A (es) 2010-12-21 2013-07-12 Nestec Sa Metodos y composiciones adecuados para manejar glucosa en sangre en animales.
US20120173151A1 (en) 2010-12-29 2012-07-05 Roche Diagnostics Operations, Inc. Methods of assessing diabetes treatment protocols based on protocol complexity levels and patient proficiency levels
WO2012097064A1 (en) 2011-01-13 2012-07-19 Abbott Laboratories Nutritional compositions and methods for controlling blood glucose
ES2569248T3 (es) 2011-01-31 2016-05-09 Cadila Healthcare Limited Tratamiento para la lipodistrofia
US10010273B2 (en) 2011-03-10 2018-07-03 Abbott Diabetes Care, Inc. Multi-function analyte monitor device and methods of use
EP2685895B1 (en) 2011-03-17 2018-10-10 University of Newcastle Upon Tyne System for the self-monitoring and regulation of blood glucose
MX339374B (es) 2011-04-29 2016-05-13 Inst De Investigación En Química Aplic S A De C V Cocristales ionicos con base en metformina.
US8968377B2 (en) 2011-05-09 2015-03-03 The Invention Science Fund I, Llc Method, device and system for modulating an activity of brown adipose tissue in a vertebrate subject
US8755938B2 (en) 2011-05-13 2014-06-17 Roche Diagnostics Operations, Inc. Systems and methods for handling unacceptable values in structured collection protocols
US8766803B2 (en) 2011-05-13 2014-07-01 Roche Diagnostics Operations, Inc. Dynamic data collection
WO2012170531A1 (en) 2011-06-07 2012-12-13 Wisconsin Alumni Research Foundation Hepatocyte based insulin gene therapy for diabetes
MX341448B (es) 2011-06-17 2016-08-19 Halozyme Inc Metodos de infusion de insulina subcutanea continua con una enzima que degrada a hialuronano.
WO2012178134A2 (en) 2011-06-23 2012-12-27 University Of Virginia Patent Foundation Unified platform for monitoring and control of blood glucose levels in diabetic patients
JP6321540B2 (ja) 2011-07-26 2018-05-09 グリセンス インコーポレイテッド 気密密閉された筐体を備える埋め込み型分析物センサおよび該センサを製造する方法
US8667293B2 (en) 2011-08-11 2014-03-04 Roche Diagnostics Operations, Inc. Cryptographic data distribution and revocation for handheld medical devices
GB2493712B (en) 2011-08-12 2014-07-02 Gene Onyx Ltd Insulin pump
WO2013024160A2 (en) 2011-08-18 2013-02-21 Novo Nordisk A/S Drug delivery device with means for handling data
WO2013040712A1 (en) 2011-09-20 2013-03-28 Afexa Life Sciences Inc. Composition comprising ku ding cha and ginseng for managing blood glucose levels
ES2984055T3 (es) 2011-09-28 2024-10-28 Abbott Diabetes Care Inc Procedimientos para la gestión de monitorización de analitos y gestión de los datos de medición de analitos, y artículos de fabricación relacionados con los mismos
US20130085682A1 (en) 2011-10-04 2013-04-04 Roche Diagnostics Operations, Inc. Memory card usage with blood glucose devices
CN103957961B (zh) 2011-10-07 2016-08-17 诺沃—诺迪斯克有限公司 用于基于三轴磁性传感器确定元件位置的系统
US20130144283A1 (en) 2011-12-02 2013-06-06 Medtronic Ardian Luxembourg S.A.R.L. Treatment of polycystic ovary syndrome using renal neuromodulation and associated systems and methods
US20140315162A1 (en) 2011-12-09 2014-10-23 Joel Ehrenkranz System and methods for monitoring food consumption
TW201333870A (zh) 2011-12-21 2013-08-16 艾登工具股份有限公司 決定病人胰島素療法的系統及方法
US9136939B2 (en) * 2011-12-29 2015-09-15 Roche Diabetes Care, Inc. Graphical user interface pertaining to a bolus calculator residing on a handheld diabetes management device
EP2797585A4 (en) 2011-12-29 2015-10-07 Latitude Pharmaceuticals Inc STABILIZED GLUCAGONNANOULULSIONS
US20130172688A1 (en) 2011-12-29 2013-07-04 Roche Diagnostics Operations, Inc. Diabetes management application for mobile phone
WO2013108262A1 (en) 2012-01-18 2013-07-25 Zota Health Care Ltd Synergistic combination for the treatment of diabetic neuropathy
US10694983B2 (en) 2012-01-19 2020-06-30 Medtronic Minimed, Inc. Method and/or system for assessing a patient's glycemic response
EP2805275A1 (en) 2012-01-20 2014-11-26 Mueller-Wolf, Martin "indima apparatus" system, method and computer program product for individualized and collaborative health care
KR101166907B1 (ko) 2012-02-08 2012-07-19 최병철 혈당조절 및 생리활성 작용을 하는 서목태(쥐눈이콩) 엑기스와 그 제조방법
CN104067131A (zh) 2012-02-10 2014-09-24 美艾利尔瑞士公司 用于确定胰岛素抗性的化验和方法
ES2421956B1 (es) 2012-03-02 2014-09-29 Moehs Ibérica S.L. Nueva forma cristalina de sulfato de sitagliptina
US9080939B2 (en) 2012-03-06 2015-07-14 National Central University Method of measuring glycosylated protein proportion by AC impedance method
AU2013230883A1 (en) 2012-03-07 2014-09-11 Medtronic Af Luxembourg S.A.R.L. Selective modulation of renal nerves
WO2013134548A2 (en) 2012-03-08 2013-09-12 Medtronic Ardian Luxembourg S.A.R.L. Ovarian neuromodulation and associated systems and methods
US20140337041A1 (en) 2012-03-30 2014-11-13 Joseph Madden Mobile Application for Defining, Sharing and Rewarding Compliance with a Blood Glucose Level Monitoring Regimen
US20130281796A1 (en) 2012-04-20 2013-10-24 Broadmaster Biotech Corp. Biosensor with exercise amount measuring function and remote medical system thereof
PH12013500989B1 (en) 2012-05-16 2019-10-16 Melaleuca Inc Dietary supplement compositions
US20150174209A1 (en) 2012-05-25 2015-06-25 Amylin Pharmaceuticals. Llc Insulin-pramlintide compositions and methods for making and using them
US20130317316A1 (en) 2012-05-25 2013-11-28 City Of Hope Carbohydrate modeling methods, systems, and devices
US9150482B2 (en) 2012-06-06 2015-10-06 Development Center For Biotechnology GLP-1 potentiators from hedychium coronarium and their applications
US9254099B2 (en) 2013-05-23 2016-02-09 Medibotics Llc Smart watch and food-imaging member for monitoring food consumption
US9536449B2 (en) 2013-05-23 2017-01-03 Medibotics Llc Smart watch and food utensil for monitoring food consumption
US9861744B2 (en) 2012-06-25 2018-01-09 International Business Machines Corporation Managing blood glucose levels
US20140012510A1 (en) 2012-07-09 2014-01-09 Dexcom, Inc Systems and methods for leveraging smartphone features in continuous glucose monitoring
US8492426B1 (en) 2012-07-12 2013-07-23 Anis Ahmad Use of carvedilol for treatment of diabetes mellitus
US20140024907A1 (en) 2012-07-19 2014-01-23 Lifescan, Inc. Method and system to indicate hyperglycemia or hypoglycemia for people with diabetes
WO2014024201A1 (en) 2012-08-06 2014-02-13 Ramchandran T S Regulate and manage blood glucose levels of a subject by promoting cell metabolism with the application of low frequency (20 khz to 70 khz ) airborne ultrasound waves and a machine to produce the airborne ultrasound waves therefor
AR092077A1 (es) 2012-08-10 2015-03-18 Sanofi Aventis Deutschland Sistema medico
WO2014028607A1 (en) 2012-08-14 2014-02-20 Abbott Laboratories Low glycemic index nutritional compositions for preserving muscle mass and improving body composition in diabetics
US9504411B2 (en) 2012-08-28 2016-11-29 Roche Diabetes Care, Inc. Diabetes manager for glucose testing and continuous glucose monitoring
US9662445B2 (en) 2012-08-30 2017-05-30 Medtronic Minimed, Inc. Regulating entry into a closed-loop operating mode of an insulin infusion system
US9171343B1 (en) * 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US9278200B2 (en) 2012-09-19 2016-03-08 Mackay Memorial Hospital Flow control device, system and method for controlling the flow of body fluid
WO2014063007A1 (en) 2012-10-18 2014-04-24 The Johns Hopkins University Real-time demand capacity and patient throughput management dashboard
EP2727587A1 (en) 2012-10-30 2014-05-07 Pharnext Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
JP6460998B2 (ja) 2012-11-13 2019-01-30 インビクタス バイオテクノロジー プロプライエタリー リミテッド トコトリエノールの経粘膜送達
EP2941265B1 (en) 2012-12-17 2021-03-31 Mygalaxy Limited Company Uses of bt lipopeptides as therapeutics for obesity and related diseases
US9351670B2 (en) 2012-12-31 2016-05-31 Abbott Diabetes Care Inc. Glycemic risk determination based on variability of glucose levels
US9192509B2 (en) 2013-03-11 2015-11-24 Avacen, Inc. Methods and apparatus for therapeutic application of thermal energy including blood viscosity adjustment
US20140296943A1 (en) 2013-03-14 2014-10-02 Biological Illumination, Llc Method for controlling blood glucose levels and digestion cycles
WO2014152704A1 (en) 2013-03-15 2014-09-25 Becton, Dickinson And Company Smart adapter for infusion devices
WO2014149781A1 (en) 2013-03-15 2014-09-25 Cercacor Laboratories, Inc. Cloud-based physiological monitoring system
CN105377118B (zh) 2013-03-15 2019-09-17 雅培糖尿病护理公司 与分析物监视设备相关联的设备、系统和方法以及包含其的设备
US9795737B2 (en) 2013-03-15 2017-10-24 Animas Corporation Method and system for closed-loop control of an artificial pancreas
WO2014162549A1 (ja) 2013-04-04 2014-10-09 テルモ株式会社 血糖管理システム
US20140303466A1 (en) 2013-04-06 2014-10-09 Applivate, LLC Computer-Based Monitoring of Blood Glucose Levels
US9237866B2 (en) 2013-04-29 2016-01-19 Birch Narrows Development, LLC Blood glucose management
WO2014187812A1 (en) 2013-05-21 2014-11-27 Novo Nordisk A/S Drug delivery device with means for disabling activation of expelling mechanism
CA2913282A1 (en) 2013-05-23 2014-11-27 Iphenotype Llc Phenotypic integrated social search database and method
US9529385B2 (en) 2013-05-23 2016-12-27 Medibotics Llc Smart watch and human-to-computer interface for monitoring food consumption
US9056049B2 (en) 2013-05-30 2015-06-16 Chin Yuan Huang Micro-particle comprising a protein extract from sweet potato for extending satiety and controlling blood glucose and lipid levels
CN103432572B (zh) 2013-06-21 2018-09-18 四川大学华西医院 一种恒河猴糖尿病肾病模型的制备方法
US9482635B2 (en) 2013-06-25 2016-11-01 Animas Corporation Glucose-measurement systems and methods presenting icons
WO2014209630A2 (en) 2013-06-27 2014-12-31 Inspark Technologies, Inc. Systems, devices, and/or methods for identifying time periods of insufficient blood glucose testing
US9898585B2 (en) * 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management

Also Published As

Publication number Publication date
IL246939A0 (en) 2016-11-02
US20150217054A1 (en) 2015-08-06
US10453568B2 (en) 2019-10-22
JP6511072B2 (ja) 2019-05-15
CA2928737A1 (en) 2015-08-06
HK1222349A1 (zh) 2017-06-30
US20180226149A1 (en) 2018-08-09
JP2017506757A (ja) 2017-03-09
EP3046600A1 (en) 2016-07-27
US20240055119A1 (en) 2024-02-15
EP3046601A4 (en) 2017-06-21
US20250253045A1 (en) 2025-08-07
US11804300B2 (en) 2023-10-31
US20190180858A1 (en) 2019-06-13
CA2927855C (en) 2022-06-21
US11081233B2 (en) 2021-08-03
US20240013913A1 (en) 2024-01-11
US20220399111A1 (en) 2022-12-15
EP3046601A1 (en) 2016-07-27
EP3046600A4 (en) 2017-07-12
US20240412863A1 (en) 2024-12-12
US20160058944A1 (en) 2016-03-03
US20150217055A1 (en) 2015-08-06
AU2015211378A1 (en) 2016-05-05
US20210020298A1 (en) 2021-01-21
US20210151183A1 (en) 2021-05-20
US11468987B2 (en) 2022-10-11
WO2015116401A1 (en) 2015-08-06
US20220359072A1 (en) 2022-11-10
US9504789B2 (en) 2016-11-29
CA2927855A1 (en) 2015-08-06
US20220037016A1 (en) 2022-02-03
US11621074B2 (en) 2023-04-04
US12027266B2 (en) 2024-07-02
US9233204B2 (en) 2016-01-12
US10255992B2 (en) 2019-04-09
WO2015116397A1 (en) 2015-08-06
IL246937A0 (en) 2016-09-29
US11158424B2 (en) 2021-10-26
US12288620B2 (en) 2025-04-29
US10811133B2 (en) 2020-10-20
EP3046601B1 (en) 2026-01-07
AU2015211382B2 (en) 2019-12-12
CA2928737C (en) 2022-06-21
US10535426B2 (en) 2020-01-14
IL246937B (en) 2020-03-31
US20230238132A1 (en) 2023-07-27
US9898585B2 (en) 2018-02-20
JP2017505696A (ja) 2017-02-23
AU2015211378B2 (en) 2019-05-16
US20170068802A1 (en) 2017-03-09
US20180366217A1 (en) 2018-12-20
US20200219607A1 (en) 2020-07-09
AU2015211382A1 (en) 2016-05-05
US20180144818A1 (en) 2018-05-24
US20200027544A1 (en) 2020-01-23
US11783946B2 (en) 2023-10-10
US11783945B2 (en) 2023-10-10
US9965595B2 (en) 2018-05-08
IL246939A (en) 2017-02-28

Similar Documents

Publication Publication Date Title
JP6539290B2 (ja) インスリン管理
JP6882383B2 (ja) インスリン管理
HK1222357B (en) Insulin management

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20170425

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171026

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20171026

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180731

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180820

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181015

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190328

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190405

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190516

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190607

R150 Certificate of patent or registration of utility model

Ref document number: 6539290

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250